Mainstream

Johnson & Johnson raises 2025 sales guidance by $2B and targets $50B oncology sales by 2030 amid robust Q2 performance

Johnson & Johnson raises 2025 sales guidance by $2B and targets $50B oncology sales by 2030 amid robust Q2 performance

Post Contentjnj, jnj:caRead More

You might also be interested in reading Coinbase Introduces New Features For Global Remittances.

July 16, 2025
In Mainstream